Loading…
Pelthos Therapeutics Inc. is projected to rise to $31.03 by 2027, a +8% move from its current price of $28.66. PTHS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $27.48 | $28.67 | $29.91 | +0.04% |
| Aug 6 | $27.01 | $28.68 | $30.46 | +0.08% |
| Aug 7 | $26.66 | $28.69 | $30.88 | +0.12% |
| Aug 8 | $26.37 | $28.71 | $31.25 | +0.16% |
| Aug 9 | $26.12 | $28.72 | $31.57 | +0.20% |
| Aug 10 | $25.90 | $28.73 | $31.87 | +0.24% |
| Aug 11 | $25.69 | $28.74 | $32.15 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $25.69 | $28.74 | $32.15 | +0.28% |
| Week 2 | $24.59 | $28.82 | $33.78 | +0.56% |
| Week 3 | $23.80 | $28.90 | $35.10 | +0.85% |
| Week 4 | $23.16 | $28.98 | $36.27 | +1.13% |
| Week 5 | $22.62 | $29.07 | $37.35 | +1.42% |
| Week 6 | $22.15 | $29.15 | $38.36 | +1.70% |
| Week 7 | $21.73 | $29.23 | $39.33 | +1.99% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pelthos Therapeutics Inc. is a healthcare company that develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI (ozenoxacin) cream for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older.
It also provides NITRICIL, a proprietary nitric oxide-based technology platform.
The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025.
Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Pelthos Therapeutics Inc. (PTHS) is a healthcare stock with a current price of $28.66. The asset operates in the Healthcare sector and focuses on therapeutic products for unmet treatment burdens.
The market capitalization is $99.61M and the rank is 4147.
The price outlook is positive over the long term, with the forecast showing the average price rising to $55.34 by 2030 and to $276.95 by 2050, supported by bullish sentiment in those years and corresponding ROIs of 93.1% and 866.3%, respectively.
A major floor 28.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 14.0% above — clearing it would confirm fresh momentum.
Key PTHS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PTHS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.20 | Buy | $27.29 | Buy |
| MA 10 | $27.09 | Buy | $27.11 | Buy |
| MA 20 | $26.71 | Buy | $27.04 | Buy |
| MA 50 | $27.07 | Buy | $26.73 | Buy |
| MA 100 | $25.44 | Buy | $26.11 | Buy |
| MA 200 | $26.17 | Buy | $25.10 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.75 | Neutral |
| Stoch RSI (14) | 95.79 | Sell |
| CCI (20) | 147.41 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 5.37 | Buy |
| Bollinger %B (20,2) | 0.94 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 57.62 | Neutral |
| Momentum (10) | 1.67 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 26.87 | Buy |
| ADX (14) | 8.56 | Neutral |
| ATR (14) | 1.11 | Info |
The near-term picture is bullish, with sentiment labeled BULLISH and RSI14 at 60.
The 50-day simple moving average is $27.07 and the 200-day simple moving average is $26.17, placing the price above both averages.
Support is at $24.33 and resistance at $29.50, with a 30-day trading range from $21.67 to $37.90.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.19 | $28.66 | $35.49 | 0% | Neutral | |
| $23.51 | $31.03 | $43.95 | +8% | Neutral | |
| $23.80 | $32.92 | $49.23 | +15% | Neutral | |
| $29.12 | $41.88 | $65.29 | +46% | Bullish | |
| $37.08 | $55.23 | $89.12 | +93% | Bullish | |
| $41.65 | $64.06 | $106.50 | +124% | Bullish | |
| $45.84 | $72.68 | $124.07 | +154% | Bullish | |
| $46.33 | $75.63 | $132.21 | +164% | Bullish | |
| $46.42 | $77.91 | $139.18 | +172% | Bullish | |
| $45.20 | $77.92 | $142.03 | +172% | Bullish | |
| $79.28 | $155.08 | $307.09 | +441% | Bullish | |
| $124.64 | $276.97 | $616.92 | +866% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $18.19 | $28.66 | $34.39 | +0.00% |
| September 2026 | $23.74 | $28.52 | $35.56 | -0.47% |
| October 2026 | $24.47 | $29.73 | $37.67 | +4.23% |
| November 2026 | $23.66 | $29.00 | $37.22 | -2.47% |
| December 2026 | $22.12 | $27.33 | $35.49 | -5.75% |
Click any year to see its month-by-month PTHS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PTHS is projected to trade between $18.19 and $35.49, averaging $28.66 — a potential gain of 0% from today's $28.66. Price action looks broadly range-bound.
Pelthos Therapeutics Inc.'s 2027 outlook centres on $31.03, within a $23.51 to $43.95 range. That is up +8% on the projected 2026 average. That marks a +8% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, PTHS could reach as high as $49.23, with a base case around $32.92 and support toward $23.80 — roughly +15% from $28.66. Price action looks broadly range-bound.
Expect PTHS to range from $29.12 to $65.29 through 2029. The $41.88 average target implies a +46% move from current prices. That is up +27% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PTHS price prediction for 2030 points to an average of $55.23 (low $37.08, high $89.12) — a potential gain of +93% on today's $28.66. Momentum favours further upside here.
In 2031, PTHS is projected to trade between $41.65 and $106.50, averaging $64.06 — a potential gain of +124% from today's $28.66. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Pelthos Therapeutics Inc.'s 2032 outlook centres on $72.68, within a $45.84 to $124.07 range. That is up +13% on the projected 2031 average. That marks a +154% change versus current levels. Momentum favours further upside here.
By 2033, PTHS could reach as high as $132.21, with a base case around $75.63 and support toward $46.33 — roughly +164% from $28.66. Buyers look set to stay in control over this stretch.
Expect PTHS to range from $46.42 to $139.18 through 2034. The $77.91 average target implies a +172% move from current prices. That is up +3% on the projected 2033 average. Momentum favours further upside here.
The PTHS price prediction for 2035 points to an average of $77.92 (low $45.20, high $142.03) — a potential gain of +172% on today's $28.66. Buyers look set to stay in control over this stretch.
In 2040, PTHS is projected to trade between $79.28 and $307.09, averaging $155.08 — a potential gain of +441% from today's $28.66. That is up +99% on the projected 2035 average. Momentum favours further upside here.
Pelthos Therapeutics Inc.'s 2050 outlook centres on $276.97, within a $124.64 to $616.92 range. That is up +79% on the projected 2040 average. That marks a +866% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PTHS today (≈ 34.891835 PTHS) could be worth
$9,664.13
+$8,664.13 (+866%) by 2050 · US Dollar
Based on the average projected PTHS price of $276.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PTHSwould be worth at today's price.
$1,000 invested in PTHS on Jul 31, 2025 (≈ 47.281325 PTHS) would be worth
$1,355.08
+$355.08 (+35.5%) today · 1.36× · US Dollar
Based on a PTHS entry price of $21.15 vs. today's $28.66.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.92 | $1,105.71 | +10.6% |
| 1 month ago | $28 | $1,023.57 | +2.4% |
| 3 months ago | $25 | $1,146.4 | +14.6% |
| 6 months ago | $25.3 | $1,132.81 | +13.3% |
| 1 year ago | $21.15 | $1,355.08 | +35.5% |
| All time (2.5y) ago | $48 | $597.08 | -40.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PTHS forecast.
Our base-case forecast reaches $57.00 around 2031.
Implied market cap at $57.00: $198.11M
The multi-year forecast shows a rising trajectory, with 2026 average price $28.66; 2030 average price $55.34; 2040 average price $154.95; and 2050 average price $276.95.
In 2030 the forecast shows min $37.15, max $89.31, and ROI 93.1 with bullish sentiment.
In 2040 the forecast shows min $79.20, max $306.83, ROI 440.6 with bullish sentiment; in 2050 min $124.63, max $616.89, ROI 866.3, sentiment bullish.
Tap a question to reveal the answer.
Avg price $55.34; max $89.31; min $37.15; ROI 93.1%; sentiment BULLISH. Note: These are estimates, not guaranteed.
In 2029, the forecast shows min $29.12, avg $41.89, max $65.31, ROI 46.1, sentiment BULLISH. Note: These are estimates, not guaranteed.
Avg $154.95; min $79.20; max $306.83; ROI 440.6; sentiment BULLISH. Note: These are estimates, not guaranteed.
Avg $276.95; min $124.63; max $616.89; ROI 866.3; sentiment BULLISH. Note: These are estimates, not guaranteed.
Current price $28.66; market cap $99.61M. Note: These are estimates, not guaranteed.
Pelthos Therapeutics Inc. Community Discussion
0Share your Pelthos Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.